Ruhanya V, Jacobs GB, Naidoo S, Paul RH, Joska JA, Seedat S, et al. Impact of Plasma IP-10/CXCL10 and RANTES/CCL5 Levels on Neurocognitive Function in HIV Treatment-Naive Patients. AIDS Res Hum Retroviruses. 2021;37(9):657-65.
Impact of Plasma IP-10/CXCL10 and RANTES/CCL5 Levels on Neurocognitive Function in HIV Treatment-Naive Patients.
By Content Specialist|2022-07-05T10:09:38+02:00July 5, 2022|2021: January to March|Comments Off on Impact of Plasma IP-10/CXCL10 and RANTES/CCL5 Levels on Neurocognitive Function in HIV Treatment-Naive Patients.
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
Corrigendum to “Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1/miR-370-3p/HMGB1 axis” [Life Sci. 2020 Dec 1; 262:118505. doi:10.1016/j.lfs.2020.118505. Epub 2020 Sep 28].